Provided by Tiger Trade Technology Pte. Ltd.

Meiragtx Holdings Plc

13.71
-0.1100-0.80%
Volume:162.64K
Turnover:2.23M
Market Cap:1.32B
PE:15.76
High:14.01
Open:13.67
Low:13.39
Close:13.82
52wk High:15.35
52wk Low:6.62
Shares:96.04M
Float Shares:53.68M
Volume Ratio:0.41
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8700
EPS(LYR):-1.4199
ROE:72.17%
ROA:38.65%
PB:6.11
PE(LYR):-9.66

Loading ...

Graviton Bioscience Announces Clearance of Investigational New Drug (Ind) for Gv101 for the Treatment of Friedreich's Ataxia

THOMSON REUTERS
·
Aug 11

MeiraGTx - Enrollment for Phase 2 Gv101 Trial Expected to Begin in Q1 2027

THOMSON REUTERS
·
Aug 11

MeiraGTx Holdings PLC Expected to Post a Loss of 46 Cents a Share - Earnings Preview

Reuters
·
Aug 10

MeiraGTx Grants New Hire 75,000 Stock Options Under Inducement Plan

Reuters
·
Aug 07

MeiraGTx Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 07

Meiragtx CFO, COO Richard Giroux Disposes of 56,000 Shares for $700,560

Reuters
·
Jul 22

MeiraGTx Holdings (MGTX) Secures Oberland Funding, Is The Stock Fully Valued?

Simply Wall St.
·
Jul 11

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Sensus Healthcare (SRTS)

TIPRANKS
·
Jul 09

MeiraGTx Royalty Deal Strengthens Funding for Commercial Launch, RBC Says

MT Newswires Live
·
Jul 08

Meiragtx Holdings Price Target Maintained with a $20.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Vera Therapeutics (VERA)

TIPRANKS
·
Jul 08

Meiragtx Chief Scientific Officer, Ophthalmology Stuart Naylor Sells USD 410,811 in Shares

Reuters
·
Jul 08

Top Midday Gainers

MT Newswires Live
·
Jul 08

Meiragtx Rises as Oberland Capital Commits up to $400 Mln for Late-stage Gene Therapies

Reuters
·
Jul 07

Meiragtx Shares up 3.5% Premarket After Co Announces $400 Mln Strategic Investment by Oberland Capital

THOMSON REUTERS
·
Jul 07

Meiragtx Holdings - Oberland Capital Has Right to Purchase Additional $15 Mln in Meiragtx Equity

THOMSON REUTERS
·
Jul 07

Press Release: Meiragtx Announces $400 Million Strategic Investment by Oberland Capital to Support Development and Commercialization of Aav2-haqp1 and Botaretigene Sparoparvovec (bota-vec)

Dow Jones
·
Jul 07

Does MeiraGTx (MGTX) Revenue Slide And Lower Institutional Ownership Reframe Its Long-Term Story?

Simply Wall St.
·
Jun 22

MeiraGTx publishes corporate deck outlining late-stage gene therapy pipeline, manufacturing platform

Reuters
·
Jun 04

MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $568,540

Reuters
·
May 20